Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2003
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534314 Methods and compositions for transforming cells
03/18/2003US6534313 A recombinant vector comprising polynucleotide sequence whose overexpression results in a dwarf phenotype; cytochrome; insect resistance and darker-green foliage
03/18/2003US6534309 Motor proteins and methods for their use
03/18/2003US6534308 Apparatus for selectively identifying, and individually targeting with energy beam, specific cells within mixed cell population to induce response in targeted cells
03/18/2003US6534305 Aerobic fermentation of preferential substances; obtain culture apparatus, dispersing and supplying air, oxygen, or a mixed gas of ammonia to culture through pipe, recover preferential substances
03/18/2003US6534300 Methods for producing highly phosphorylated lysosomal hydrolases
03/18/2003US6534299 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects
03/18/2003US6534297 Recombinantly producing levodione reductase
03/18/2003US6534290 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
03/18/2003US6534289 Recombinant nucleic acid encoding receptor having amino acid sequences of extracellular domain of G-protein coupled calcium receptor, seven-transmembrane and intracellular cytoplasmic tail domains of group I metabotropic glutamate receptor
03/18/2003US6534280 Noninvasive detection of colorectal cancer and other gastrointestinal pathology
03/18/2003US6534268 Isolated nucleic acid corresponding to specified nucleotide sequence that encodes human bone morphogenetic protein-7 promoter region
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534101 Enzymes mixture obtained from Penicillium funiculosum
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534055 Methods for selectively stimulating proliferation of T cells
03/18/2003US6534052 Cardiac function comprising implantation of embryonic stem cell in which differentiation has been initiated
03/18/2003US6534050 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes
03/18/2003US6534036 Biological materials and methods useful in the diagnosis and treatment of diseases
03/18/2003CA2277995C Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
03/18/2003CA2210449C Method for preparing macrophages, and kits and compositions therefor
03/18/2003CA2165694C Erythropoietin analogs
03/18/2003CA2141334C Cationic lipids
03/18/2003CA2121370C Specific tolerance in transplantation
03/18/2003CA2045175C Production of proteins using homologous recombination
03/18/2003CA2005016C Dna fragment containing promoter region for human polypeptide chain elongation factor-1.alpha. and expression plasmid containing the dna fragment
03/18/2003CA1341425C Antibodies to angiogenin: immunotherapeutic agents
03/17/2003WO2002022833A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2422759A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2403157A1 Dna encoding the baboon and cynomolgus macaque prostaglandin e2 receptor ep4 subtype
03/17/2003CA2403058A1 Dna encoding the chimpanzee prostaglandin e2 receptor ep4 subtype
03/14/2003CA2357403A1 A pax-encoding vector and use thereof
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003021265A1 Genetic construct intracellular monitoring system
03/13/2003WO2003020986A1 Method of isolating cells and uses thereof
03/13/2003WO2003020956A2 Nucleid acid compositions conferring herbicide resistance
03/13/2003WO2003020955A2 Use of recipient endothelial cells for enhanced vascularization of tissue and tissue-engineered construct transplants
03/13/2003WO2003020954A2 205p1b5 in treatment and detection of cancer
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020938A2 Method of protein production in plants
03/13/2003WO2003020931A2 Sirna knockout assay method and constructs
03/13/2003WO2003020930A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
03/13/2003WO2003020928A2 Identification of eukaryotic internal ribosome entry site (ires) elements
03/13/2003WO2003020927A2 Creation of artificial internal ribosome entry site (ires) elements
03/13/2003WO2003020920A1 Culture system for rapid expansion of human embryonic stem cells
03/13/2003WO2003020919A2 A unit and a process for carrying out high cell density fermentation
03/13/2003WO2003020916A2 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
03/13/2003WO2003020915A2 Non-linear amplitude dielectrophoresis waveform for cell fusion
03/13/2003WO2003020908A2 Multi-lineage directed induction of bone marrow stromal cell differentiation
03/13/2003WO2003020904A2 Methods of generating human cd4+ th1 cells
03/13/2003WO2003020896A2 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
03/13/2003WO2003020894A2 Insulin related transcription factor and uses thereof
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
03/13/2003WO2003020890A2 Genes encoding baeyer-villiger monooxygenases
03/13/2003WO2003020889A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003WO2003020884A2 Method for rapid generation of mature dendritic cells
03/13/2003WO2003020877A2 Staining and sorting genomes and chromosomes using sequence-specific polyamides
03/13/2003WO2003020876A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003WO2003020871A2 Method and device for the in vitro cultivation of cells
03/13/2003WO2003020771A1 Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use
03/13/2003WO2003020769A1 Pemphigus monoclonal antibody
03/13/2003WO2003020763A2 Soluble t cell receptor
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020757A2 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
03/13/2003WO2003020749A2 Ncam binding compounds
03/13/2003WO2003020746A1 Modified transferrin fusion proteins
03/13/2003WO2003020257A2 USE OF β-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
03/13/2003WO2003020191A1 Cellulose membranes for biodegradable scaffolds
03/13/2003WO2003020104A2 Method of treating systemic inflammatory response syndrome
03/13/2003WO2003020039A1 Immune tolerance to predetermined antigens
03/13/2003WO2003020013A1 Plant-derived resistance gene
03/13/2003WO2003020005A2 Lp mammalian proteins; related reagents
03/13/2003WO2002097066A8 Human vascular progenitor cells
03/13/2003WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/13/2003WO2002095055A8 Compositions and methods for use in isolation of nucleic acid molecules
03/13/2003WO2002095006A3 Muscle-specific expression vectors
03/13/2003WO2002094198A3 Modulation of cell division by an early mitotic inhibitor protein
03/13/2003WO2002091997A3 Oncolytic virus therapy
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002077213A3 New elongase gene and production of δ9-polyunsaturated fatty acids
03/13/2003WO2002075275A3 Polyclonal populations of bispecific molecules and methods of production and uses thereof
03/13/2003WO2002074979A3 Expression profiles and methods of use
03/13/2003WO2002074158A3 Two-phase processing of thermosensitive polymers for use as biomaterials
03/13/2003WO2002072634A3 Recombinant proteinase k
03/13/2003WO2002067762A3 Muscle-polymer constructs for bone tissue engineering
03/13/2003WO2002064629A3 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
03/13/2003WO2002063938A3 Production and use of dopaminergic cells to treat dopaminergic deficiencies
03/13/2003WO2002063012A3 Ragweed allergens
03/13/2003WO2002060396A3 Hair follicle neogenesis by injection of follicle progenitor cells
03/13/2003WO2002059277A3 Electroactive materials for stimulation of biological activity of stem cells
03/13/2003WO2002050286A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/13/2003WO2002048363A3 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/13/2003WO2002046407A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002044380A3 Master bone formation transcription factor: compositions and methods of use
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002044364A3 Polypeptides involved in immune response
03/13/2003WO2002042456A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
1 ... 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 ... 1827